Department of Medical Ethics and History of Medicine, University Medical Center Goettingen, Humboldtallee 36 / 37073, Goettingen, Germany.
Department of Health Sciences, Hamburg University of Applied Sciences, Ulmenliet 20 / 21033, Hamburg, Germany.
BMC Public Health. 2023 Dec 13;23(1):2492. doi: 10.1186/s12889-023-17249-4.
Since spring 2020, the SARS-CoV-2 virus has spread worldwide, causing dramatic global consequences in terms of medical, care, economic, cultural and bioethical dimensions. Although the resulting conflicts initially appeared to be quite similar in most countries, a closer look reveals a country-specific intensification and differentiation of issues. Our study focused on understanding and highlighting bioethical conflicts that were triggered, exposed or intensified by the COVID-19 pandemic in low and middle-income countries (LMICs) and high-income countries (HICs).
We conducted qualitative interviews with 39 ethics experts from 34 countries (Argentina, Australia, Austria, Brazil, Canada, Colombia, Denmark, Ecuador, Ethiopia, France, Germany, India, Italy, Israel, Japan, Kyrgyzstan, Mexico, Nigeria, Oman, Pakistan, Paraguay, Poland, Romania, Russia, Singapore, South Korea, Spain, Sweden, South Africa, Tunisia, Türkiye, United-Kingdom, United States of America, Zambia) from November 2020 to March 2021. We analysed the interviews using qualitative content analysis.
The scale of the bioethical challenges between countries differed, as did coping strategies for meeting these challenges. Data analysis focused on: a) Resource scarcity in clinical contexts: Scarcity of medical resources led to the need to prioritize the care of some COVID-19 patients in clinical settings globally. Because this entails the postponement of treatment for other patients, the possibility of serious present or future harm to deprioritized patients was identified as a relevant issue. b) Health literacy: The pandemic demonstrated the significance of health literacy and its influence on the effective implementation of health measures. c) Inequality and vulnerable groups: The pandemic highlighted the context-sensitivity and intersectionality of the vulnerabilities of women and children in LMICs and the aged in HICs. d) Conflicts surrounding healthcare professionals: The COVID-19 outbreak underscored the tough working conditions for nurses and other health professionals, raising awareness of the need for reform.
The pandemic exposed pre-existing structural problems in LMICs and HICs. Without neglecting individual contextual factors in the observed countries, we created a mosaic of different voices of experts in bioethics across the globe, drawing attention to the need for international solidarity in the context of a global crisis.
自 2020 年春季以来,SARS-CoV-2 病毒在全球范围内传播,在医疗、护理、经济、文化和生物伦理等方面造成了巨大的全球后果。尽管最初大多数国家的冲突似乎非常相似,但仔细观察就会发现,各国的问题呈现出特定的加剧和分化。我们的研究重点是了解和突出在中低收入国家(LMICs)和高收入国家(HICs)中由 COVID-19 大流行引发、暴露或加剧的生物伦理冲突。
我们于 2020 年 11 月至 2021 年 3 月期间对来自 34 个国家(阿根廷、澳大利亚、奥地利、巴西、加拿大、哥伦比亚、丹麦、厄瓜多尔、埃塞俄比亚、法国、德国、印度、意大利、以色列、日本、吉尔吉斯斯坦、墨西哥、尼日利亚、阿曼、巴基斯坦、巴拉圭、波兰、罗马尼亚、俄罗斯、新加坡、韩国、西班牙、瑞典、南非、突尼斯、土耳其、英国、美国、赞比亚)的 39 名伦理专家进行了定性访谈。我们使用定性内容分析对访谈进行了分析。
各国之间的生物伦理挑战规模不同,应对这些挑战的策略也不同。数据分析集中在:a)临床环境中的资源匮乏:医疗资源的匮乏导致全球范围内需要优先照顾某些 COVID-19 患者的治疗。因为这意味着推迟了对其他患者的治疗,因此,被优先级降低的患者可能会面临严重的当前或未来的伤害,这被认为是一个相关问题。b)健康素养:大流行凸显了健康素养的重要性及其对有效实施卫生措施的影响。c)不平等和弱势群体:大流行突显了中低收入国家妇女和儿童的脆弱性以及高收入国家老年人的脆弱性的背景敏感性和交叉性。d)围绕医疗保健专业人员的冲突:COVID-19 疫情凸显了护士和其他卫生专业人员的艰苦工作条件,引起了人们对改革的关注。
大流行暴露了中低收入国家和高收入国家预先存在的结构性问题。我们没有忽视观察到的国家中的个别背景因素,而是创建了一个由来自全球各地的生物伦理专家不同声音组成的马赛克,提请人们注意在全球危机背景下需要国际团结。